Andrea Antinori

Andrea Antinori

UNVERIFIED PROFILE

Are you Andrea Antinori?   Register this Author

Register author
Andrea Antinori

Andrea Antinori

Publications by authors named "Andrea Antinori"

Are you Andrea Antinori?   Register this Author

100Publications

2041Reads

44Profile Views

Vitamin D deficiency is associated with neurocognitive impairment in HIV-infected subjects.

Infection 2019 Jun 10. Epub 2019 Jun 10.

HIV/AIDS Department, National Institute for Infectious Diseases, IRCCS, Lazzaro Spallanzani, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s15010-019-01313-6DOI Listing
June 2019

Unawareness of HCV serostatus among persons newly diagnosed with HIV.

J Infect Public Health 2019 Feb 5. Epub 2019 Feb 5.

Clinical Epidemiology Unit - National Institute for Infectious Diseases "Lazzaro Spallanzani" - IRCCS, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jiph.2019.01.055DOI Listing
February 2019

Impact of antiretroviral and tuberculosis therapies on CD4 and CD8 HIV/M. tuberculosis-specific T-cell in co-infected subjects.

Immunol Lett 2018 06 7;198:33-43. Epub 2018 Apr 7.

Translational Research Unit, Department of Epidemiology and Preclinical Research, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Via Portuense 292, 00149 Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2018.04.001DOI Listing
June 2018

IL-18 and Stem Cell Factor affect hematopoietic progenitor cells in HIV-infected patients treated during primary HIV infection.

Cytokine 2018 03 8;103:34-37. Epub 2018 Jan 8.

Cellular Immunology Laboratory, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2017.12.033DOI Listing
March 2018

UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.

J Chromatogr B Analyt Technol Biomed Life Sci 2018 Jan 12;1073:183-190. Epub 2017 Dec 12.

Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "Lazzaro Spallanzani", IRCCS, Rome, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2017.12.018DOI Listing
January 2018

Brief Report: Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression.

J Acquir Immune Defic Syndr 2017 12;76(4):417-422

*Malattie Infettive, IRCCS San Raffaele, Milano, Italy; †Dipartimento di Scienze della Salute, Clinica Malattie Infettive e Tropicali, ASST Santi Paolo e Carlo, Milano, Italy; ‡Area Dipartimentale HIV/AIDS, Istituto Nazionale per le Malattie Infettive L. Spallanzani IRCCS, Roma, Italy; §Clinic of Infectious Diseases, Univesity of Bari, Bari, Italy; ‖Clinic of Infectious Diseases, "San Gerardo" Hospital-ASST Monza, University Milano-Bicocca, Milano, Italy; ¶Malattie Infettive, ASST Fatebenefratelli Sacco, Milano, Italy; #Department of Public Health and Infectious Disease, Malattie Infettive, Sapienza University of Rome, polo Pontino, Roma, Italy; **Malattie Infettive, Università degli Studi, Policlinico di Modena, Modena, Italy; ††Unitá di Epidemiologia Clinica, Istituto Nazionale per le Malattie Infettive L. Spallanzani IRCCS, Roma, Italy; and ‡‡Infection and Population Health, Institute of Global Health, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001522DOI Listing
December 2017

Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV.

J Acquir Immune Defic Syndr 2017 11;76(3):e74-e83

*Research Department of Infection and Population Health, University College London, London, United Kingdom; †National Institute for Infectious Diseases, Lazzaro Spallanzani, Rome, Italy; ‡Department of Infectious Diseases, University of Copenhagen, Copenhagen, Denmark; §Belarusian State Medical University, Minsk, Belarus; and ∥HIV i-Base, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001468DOI Listing
November 2017

Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.

PLoS One 2017 24;12(8):e0183846. Epub 2017 Aug 24.

Translational Research Unit, Department of Epidemiology and Preclinical Research, "L. Spallanzani" National Institute for Infectious Diseases (INMI), Rome, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183846PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570327PMC
October 2017

In HIV/HCV co-infected patients T regulatory and myeloid-derived suppressor cells persist after successful treatment with directly acting antivirals.

J Hepatol 2017 08 12;67(2):422-424. Epub 2017 Apr 12.

Department of Epidemiology, Pre-clinical Research and Advanced Diagnostic, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.03.036DOI Listing
August 2017

Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated With Incident and Prevalent Type 2 Diabetes in Persons Living With HIV.

J Acquir Immune Defic Syndr 2017 08;75(4):465-471

*Dipartimento di Biotecnologie Mediche, Università degli Studi di Siena;†UOC Malattie Infettive Universitarie ed Epatologia, Dipartimento di Medicina Interna e Specialistica, Azienda Ospedaliera Universitaria Senese, Siena, Italy;‡National Institute for Infectious Diseases "L Spallanzani, Roma, Italy;§Division of Infectious Diseases, Hospital San Raffaele, Milan, Italy;‖Division of Infectious Diseases, Niguarda Hospital, Milan, Italy;¶Department of Infectious Diseases, University of Brescia, Brescia, Italy;#Division of Infectious Diseases, AO Giovanni XXIII, Bergamo, Italy;**Division of Infectious Diseases, University La Sapienza, Polo Pontino, Latina, Italy;††INMI "L Spallanzani," Rome, Italy;‡‡Division of Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy;§§Division of Infectious Diseases, University La Sapienza, Polo Pontino, Latina, Italy; and‖‖Division of Infectious Diseases, University of Milan, San Paolo Hospital, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001443DOI Listing
August 2017

HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.

J Acquir Immune Defic Syndr 2017 07;75(3):338-344

*Laboratory of Cellular Immunology and Pharmacology, Department of Epidemiology, Preclinical Research and Advanced Diagnostic, National Institute for Infectious Diseases "Lazzaro Spallanzani," IRCCS, Rome, Italy; †Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani," IRCCS, Rome, Italy; ‡Laboratory of Translational Immunology, Humanitas Clinical and Research Center, Milano, Italy; and §Division of Hematologic Malignancies, Stem Cell Transplantation Institute, City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001392DOI Listing
July 2017

Granulocytic Myeloid-Derived Suppressor Cells Increased in Early Phases of Primary HIV Infection Depending on TRAIL Plasma Level.

J Acquir Immune Defic Syndr 2017 04;74(5):575-582

*Cellular Immunology Laboratory, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, Rome, Italy; †Clinical Division, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, Rome, Italy; and ‡Virology Laboratory, "Lazzaro Spallanzani" National Institute for Infectious Diseases, IRCCS, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001283DOI Listing
April 2017

Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial.

J Acquir Immune Defic Syndr 2017 Feb;74(2):185-192

*Department of Medicine, Imperial College London, London, United Kingdom; †MRC Clinical Trials Unit, UCL, London, United Kingdom; ‡Clinical Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy; §Univ Bordeaux, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, Bordeaux, France; ‖Infectious Diseases Department, CHD Vendee, La Roche sur Yon, France; ¶Division of Infectious Diseases, Saint Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium; #Infectious Diseases Department, Gui de Chauliac Hospital, Montpellier, France; **North Bristol NHS Trust, Bristol, United Kingdom; ††Department of Health Sciences, Clinic of Infectious and Tropical Diseases, San Paolo University Hospital, Milan, Italy; ‡‡Infectious Diseases Department, The Hospital Clinic, Institut d'investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain; §§Department of Infectious Diseases and Rheumatology, Centre for Health and Infectious Disease Research (CHIP), Rigshospitalet, Copenhagen, Denmark; ‖‖Chelea and Westminster NHS Foundation Trust, London, United Kingdom; ¶¶CMIT, Paris, France; and ##CHU de Bordeaux, Pole de sante publique, and CIC1401-EC (Clinical Epidemiology), Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001189DOI Listing
February 2017

Chronic Hepatitis B and C Virus Infection and Risk for Non-Hodgkin Lymphoma in HIV-Infected Patients: A Cohort Study.

Ann Intern Med 2017 01 18;166(1):9-17. Epub 2016 Oct 18.

From Basel Institute for Clinical Epidemiology & Biostatistics, University Hospital Basel, Basel, Switzerland; University of Siena, Siena, Italy; University College London, London, United Kingdom; Innsbruck Medical University, Innsbruck, Austria; University of Athens, Athens, Greece; Université Bordeaux, Bordeaux, France; Stichting HIV Monitoring, Amsterdam, the Netherlands; University Hospital of Cologne, Cologne, Germany; Hospital General Universitario Gregorio Marañón, Madrid, Spain; Rigshospitalet, Copenhagen, Denmark; IRCCS Ospedale San Raffaele, Milan, Italy; National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy; University of Brescia, Brescia, Italy; University of Modena and Reggio Emilia, Modena, Italy; University of Barcelona, Barcelona, Spain; Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium; and University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M16-0240DOI Listing
January 2017

High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects: Data from the ICONA Foundation Cohort.

Medicine (Baltimore) 2016 Sep;95(36):e4434

aInfectious Diseases Clinic, San Gerardo Hospital, University of Milano-Bicocca, Monza bInfectious Diseases Department, San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan cUnit of Infectious Diseases, Department of Clinical and Experimental Medicine, University of Sassari, Sassari dInfectious and Tropical Diseases Unit I, Department of Infectious Diseases, Amedeo di Savoia Hospital, Torino eClinical Department, National Institute of Infectious Diseases 'L.Spallanzani', Rome fDivision of Infectious Diseases, Padova Hospital, Padova gDivision of Infectious Diseases, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo hDepartment of Publich Health, Infectious Diseases, Catholic University, Rome iDepartment of Health Sciences, Clinic of Infectious Diseases, 'San Paolo' Hospital, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000004434DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023860PMC
September 2016

Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective.

Clin Drug Investig 2016 May;36(5):377-87

Economic Evaluation and HTA (CEIS-EEHTA)-IGF Department, Faculty of Economics, University of Rome "Tor Vergata", Via Columbia 2, 00133, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-016-0382-2DOI Listing
May 2016

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study.

J Acquir Immune Defic Syndr 2016 Apr;71(5):538-43

*Infectious Diseases Unit, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; †ViiV Healthcare, Brentford, United Kingdom; ‡Chelsea and Westminster NHS Foundation Trust Hospital, London, United Kingdom; §Infectious Diseases & AIDS Units, Clinical Institute of Medicine & Dermatology, Hospital Clinic, University of Barcelona, Barcelona, Spain; ‖National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy; ¶Bristol-Myers Squibb, Rueil-Malmaison, France; #Bristol-Myers Squibb, Madrid, Spain; **Bristol-Myers Squibb, Uxbridge, United Kingdom; ††Triple O Research Institute PA, West Palm Beach, FL; ‡‡Bristol-Myers Squibb, Princeton, NJ; §§Department of Infectious and Tropical Diseases, Hôpital St Antoine, Assistance Publique-Hôpitaux de Paris, Paris, France; and ‖‖Institut Pierre-Louis d'Epidémiologie et Santé Publique, Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche en Santé n°1136, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804741PMC
April 2016

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.

J Acquir Immune Defic Syndr 2016 Mar;71(3):263-71

*Infectious Diseases Unit, IRCCS AOU S. Martino-IST, National Institute for Cancer Research, Genoa, Italy;†Department of Infection and Population Health, Division of Population Health, UCL Medical School, Royal Free Campus, London, United Kingdom;‡Department of Biomedical Science and Human Oncology, University of Bari, Bari, Italy;§Clinic of Infectious Diseases, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy;‖Infectious Diseases Unit, Busto Arsizio Hospital, Busto Arsizio (VA), Italy;¶Infectious Diseases Unit, Siena University Hospital, Siena, Italy;#Department of Health Sciences, University of Ancona, Ancona, Italy;**Infectious Diseases Clinic, Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy;††Infectious Diseases Unit, Sacco Hospital, Milan, Italy;‡‡Infectious Diseases Unit, Vita-Salute University, San Raffaele Scientific Institute, Milan, Italy;§§National Institute for Infectious Diseases IRCCS L. Spallanzani, Rome, Italy; and‖‖Clinic of Infectious and Tropical Diseases, Department of Health Sciences, S Paolo Hospital, University of Milan, Milan, Italy.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/jaids/9000/00000/Discontinuatio
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000000849DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770376PMC
March 2016

Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults: week 96 efficacy and safety from a randomized phase 3b study.

AIDS 2016 Jan;30(2):251-9

aUniversity Medical Centre, Hamburg-Eppendorf, Infectious Diseases Unit, Hamburg, Germany bNational Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy cGilead Sciences, Inc., Foster City, California, USA dHospital Universitario La Paz, IdiPAZ, Madrid, Spain eUniversity of North Carolina, Chapel Hill, North Carolina, USA fMedical University of Vienna, Vienna, Austria gUniversity of Toronto, Toronto, Ontario, Canada hHoldsworth House Medical Practice, Sydney, Australia iNew York Hospital Queens, Flushing, New York, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2016/01140/Rilpiviri
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000911DOI Listing
January 2016

Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort.

J Acquir Immune Defic Syndr 2015 Dec;70(4):e147-50

*Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzabi", IRCCS, Rome, Italy †Department of Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy ‡Division of Infectious Diseases, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy §Division of Infectious Diseases, Department of Internal Medicine, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy ‖Division of Infectious Diseases, "Careggi" Hospital, Florence, Italy ¶Division of Infectious Diseases and Dermatology, San Gallicano Institute, IRCCS, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000727DOI Listing
December 2015

Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.

AIDS 2015 Nov;29(18):2534-7

aClinical Department, National Institute of Infectious Disease 'L. Spallanzani' bDepartment of Obstetrics and Gynecology, Catholic University of the Sacred Heart cInstitutes of Infectious Diseases, Catholic University of the Sacred Heart dDepartment of Immunology and Infectious Diseases, 'Bambino Gesù' Children's Hospital eDepartment of Experimental Medicine and Surgery, University of Rome Tor Vergata fDepartment of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000000888DOI Listing
November 2015

Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues.

AIDS 2015 Sep;29(14):1811-20

aNational Institute for Infectious Diseases, L. Spallanzani IRCCS, Rome, Italy bBrighton and Sussex University Hospitals, Brighton, UK cKarolinska University, Sjukhuset, Sweden dHospital Universitario La Paz, IdiPAZ, Madrid, Spain eMedical Research Council, HIV Clinical Trials Unit, London, UK fDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland gCopenhagen University Hospital, Copenhagen, Denmark hWarsaw Medical University, Infectious Diseases, Warsaw, Poland iUniversity Hospital Germans Trias I Pujol, irsiCaixa, Badalona, Spain jInfectious Diseases, Ospedale Papa Giovanni XXIII, Bergamo, Italy kDepartment of Infectious and Tropical Diseases, Hôpital Saint-Antoine, AP-HP, and INSERM UMR S 1136, Paris, France lUniversity of Liverpool, Liverpool, UK mJanssen, EMEA, Neuss, Germany.

View Article

Download full-text PDF

Source
http://www.natap.org/2015/HIV/Week_48_efficacy_and_central_n
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/QAD.0000000000000778DOI Listing
September 2015

stARTing cART now! HIV treatment Italian Guidelines Update Dec. 2014.

New Microbiol 2015 Jul;38(3):297-8

View Article

Download full-text PDF

Source
July 2015

HEFFICON: HIV Effectiveness Italian Conference.

New Microbiol 2015 Apr;38(2):149-84

Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.

View Article

Download full-text PDF

Source
April 2015